In: Economics
The health authorities are considering the treatment alternatives for three types of diseases: heart disease, cancer, and infectious disease. Each year there are 10,000 new cases of heart disease, 10,000 new cases of cancer, and 5,000 new cases of infectious disease. For each diagnosis, there are a number of mutually independent treatment alternatives (including no treatment) as shown in the following table.
Treatment | Cost per treatment | QALY gained |
Heart Disease | ||
A | 0 | 0 |
B | 100 | 2 |
C | 300 | 8 |
D | 400 | 8 |
E | 600 | 12 |
F | 800 | 15 |
Cancer | ||
G | 0 | 0 |
H | 200 | 8 |
I | 400 | 10 |
J | 500 | 12 |
K | 600 | 9 |
L | 700 | 14 |
M | 800 | 15 |
Infectious Disease | ||
N | 0 | 0 |
O | 100 | 2 |
P | 350 | 4 |
R | 650 | 6 |
a) identify all dominant treatment alternatives. Explain why each is dominant
b) Calculate the incremental cost, incremental QALY's, and ICERs for all economically rational strategies (ICER= incremental cost / incremental QALYs). Why are these considered economically rational?
c) using separate graphs for heart disease, cancer, and infectious disease, show the alternative treatment options, label the dominant options, and show the economically feasible alternatives. (Place QALYs on the vertical axis and cost per treatment on the horizontal axis)
d) the local health district has asked your opinion on the "best" strategy from a public health perspective (disease covered, treatment strategy). What do you tell them? How much will it cost?
a. and b. please see table below
Treatment | Cost per treatment | QALY gained | Cost / QALY | Incremental Cost | Incremental QALY | Incremental Cost / Incremental QALY | |
Heart Disease | |||||||
A | 0 | 0 | |||||
B | 100 | 2 | 50 | 100 | 2 | 50 | |
C | 300 | 8 | 38 | 200 | 6 | 33 | Dominant alternative since the cost / QALY is the lowest |
D | 400 | 8 | 50 | 100 | 0 | undefined | Economically irrational from the standpoint of the patient since there is no incremental QALY with additional cost |
E | 600 | 12 | 50 | 200 | 4 | 50 | |
F | 800 | 15 | 53 | 200 | 3 | 67 | |
Cancer | |||||||
G | 0 | 0 | |||||
H | 200 | 8 | 25 | 200 | 8 | 25 | Dominant alternative since the cost / QALY is the lowest |
I | 400 | 10 | 40 | 200 | 2 | 100 | |
J | 500 | 12 | 42 | 100 | 2 | 50 | |
K | 600 | 9 | 67 | 100 | -3 | -33 | Economically irrational from the standpoint of the hospitals since incremental QALY cost negative |
L | 700 | 14 | 50 | 100 | 5 | 20 | |
M | 800 | 15 | 53 | 100 | 1 | 100 | |
Infectious Disease | |||||||
N | 0 | 0 | |||||
O | 100 | 2 | 50 | 100 | 2 | 50 | Dominant alternative since the cost / QALY is the lowest |
P | 350 | 4 | 88 | 250 | 2 | 125 | |
R | 650 | 6 | 108 | 300 | 2 | 150 |
c. pls see graphs below
d. the recommended treatments are C, H and O, respectively for Heart Disease, Cancer and Infectious Disease, as the Cost / QALY is the lowest for these. The total cost of treatment of all new patients each year is shown in the table below.
Number of patients | Suggested Treatment | Cost / Treatment | Total Cost | |
Heart Disease | 10,000 | C | 300 | 30,00,000 |
Cancer | 10,000 | H | 200 | 20,00,000 |
Infectious Disease | 5,000 | O | 100 | 5,00,000 |
Total | 25,000 | 55,00,000 |